<DOC>
	<DOCNO>NCT00519753</DOCNO>
	<brief_summary>The purpose study assess safety efficacy transition uncontrolled glaucoma patient DuoTrav mono adjunctive therapy .</brief_summary>
	<brief_title>Success Transitioning Uncontrolled Glaucoma Patients From Prior Mono Adjunctive Therapy DuoTrav</brief_title>
	<detailed_description />
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Travoprost</mesh_term>
	<mesh_term>Timolol</mesh_term>
	<mesh_term>Maleic acid</mesh_term>
	<mesh_term>Cloprostenol</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Adults primary openangle glaucoma , ocular hypertension pigment dispersion glaucoma . Other protocoldefined inclusion criterion may apply . Age related . Other protocoldefined exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>Glaucoma</keyword>
</DOC>